| NCT05808634 | Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma. | RECRUITING | PHASE1 | 2023-07-14 | 2028-09-15 | 2028-09-15 |
| NCT05271604 | A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | COMPLETED | PHASE2 | 2022-12-13 | 2025-09-22 | 2025-09-22 |
| NCT05180799 | A Phase 1/2 Study of BA3071 in Patients With Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2022-08-03 | 2026-06-30 | 2025-03-19 |
| NCT04681131 | CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC | COMPLETED | PHASE2 | 2021-03-17 | 2025-07-09 | 2025-07-09 |
| NCT03504488 | CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) | COMPLETED | PHASE1, PHASE2 | 2018-06-27 | 2024-12-30 | 2024-12-30 |
| NCT03425279 | CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma | COMPLETED | PHASE1, PHASE2 | 2018-02-15 | 2025-01-08 | 2025-01-08 |